In the past 52-week period, shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) have moved within the range of $1.01 to $3.24. On the stock’s most recent trading day, the company’s shares ended the regular session at $2.91, which is 10.19% higher than its 52-week high.
Catalyst Pharmaceuticals, Inc. (CPRX) has demonstrated a 20-day simple moving average (SMA) of 1.31%, and a 50-day SMA of 8.48%. This public company’s current market capitalization stands at $256.31 million.Analyzing Consensus Estimates, Sales Revenue and Net Income
Checking the amount of enthusiasm that Wall Street analysts hold for a particular stock is crucial when thinking about entering a position. According to the latest data, the consensus recommendation for Catalyst Pharmaceuticals, Inc. (CPRX) is Outperform.
Public companies normally post earnings and revenue results that fall somewhat above or below the average Wall Street estimate. In the most recent quarterly financial report, for the quarter ending Sep. 2017, Catalyst Pharmaceuticals, Inc. (CPRX) delivered a 0.00% surprise with its net revenue.
Meanwhile, during the same quarter Catalyst Pharmaceuticals, Inc. (CPRX) delivered a -9.09% earnings surprise. Net earnings for the quarter were posted at -$0.05 per share, whereas Wall Street had forecast -$0.05 per share.Ownership at Catalyst Pharmaceuticals, Inc. (CPRX), According to Most Recent SEC Filings
A publicly-traded organization’s latest 13F filings tell us important details about its institutional ownership. Catalyst Pharmaceuticals, Inc. (CPRX) has 0 billion shares outstanding currently, 41.37% of which belong to institutional investors. Those institutional holdings amount to $0.1 billion.
Additionally, according to the most recent 13F filing from Catalyst Pharmaceuticals, Inc. (CPRX), there were 15 new positions totaling 1,241,993 shares of the company’s stock. There were 3 sold out positions, on the other hand, totaling 98,802 shares.Short, Medium and Long Term Indicators
Assessing the average trade volume of a public company’s stock in the short, medium and long term is helpful to gain an understanding of trading activity and investor sentiment. Catalyst Pharmaceuticals, Inc. (CPRX) has had a 20-day average volume of 1,030,990 shares, with an average of 20% of short term indicators pointed at Buy.
The stock’s 50-day average volume has been 672,934 shares, with an average of 25% of medium term indicators pointing toward Buy. Finally, its 100-day average volume is 756,292 shares with 0% of long-term indicators pointing to Hold.